0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Preimplantation Genetic Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-35H2599
Home | Market Reports | Health| Reproductive Health
Global Preimplantation Genetic Diagnosis Market Insights and Forecast to 2028
BUY CHAPTERS

Preimplantation Genetic Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35H2599
Report
October 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Preimplantation Genetic Diagnosis - Market Size

The global market for Preimplantation Genetic Diagnosis was estimated to be worth US$ 493 million in 2023 and is forecast to a readjusted size of US$ 914 million by 2030 with a CAGR of 8.9% during the forecast period 2024-2030

Preimplantation Genetic Diagnosis - Market

Preimplantation Genetic Diagnosis - Market

Preimplantation Genetic Diagnosis (PGD) is a technique used for detecting genetic defects in embryos developed through in vitro fertilization (IVF) before pregnancy. PGD involves performing tests on embryos to determine genetic abnormality. PGD is an alternative to current post conception diagnostic procedures.
North American market for Preimplantation Genetic Diagnosis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preimplantation Genetic Diagnosis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Preimplantation Genetic Diagnosis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Preimplantation Genetic Diagnosis include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Diagnosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Preimplantation Genetic Diagnosis by region & country, by Type, and by Application.
The Preimplantation Genetic Diagnosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Diagnosis.
Market Segmentation

Scope of Preimplantation Genetic Diagnosis - Market Report

Report Metric Details
Report Name Preimplantation Genetic Diagnosis - Market
Forecasted market size in 2030 US$ 914 million
CAGR 8.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Genetic Diagnosis
  • Genetic Screening
Segment by Application
  • Fertility Clinics
  • Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics, Oxford Gene Technology, Yikon Genomics, Scigene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Preimplantation Genetic Diagnosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Preimplantation Genetic Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Preimplantation Genetic Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Preimplantation Genetic Diagnosis - Market size in 2030?

Ans: The Preimplantation Genetic Diagnosis - Market size in 2030 will be US$ 914 million.

Who are the main players in the Preimplantation Genetic Diagnosis - Market report?

Ans: The main players in the Preimplantation Genetic Diagnosis - Market are Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics, Oxford Gene Technology, Yikon Genomics, Scigene

What are the Application segmentation covered in the Preimplantation Genetic Diagnosis - Market report?

Ans: The Applications covered in the Preimplantation Genetic Diagnosis - Market report are Fertility Clinics, Research

What are the Type segmentation covered in the Preimplantation Genetic Diagnosis - Market report?

Ans: The Types covered in the Preimplantation Genetic Diagnosis - Market report are Genetic Diagnosis, Genetic Screening

1 Market Overview
1.1 Preimplantation Genetic Diagnosis Product Introduction
1.2 Global Preimplantation Genetic Diagnosis Market Size Forecast
1.3 Preimplantation Genetic Diagnosis Market Trends & Drivers
1.3.1 Preimplantation Genetic Diagnosis Industry Trends
1.3.2 Preimplantation Genetic Diagnosis Market Drivers & Opportunity
1.3.3 Preimplantation Genetic Diagnosis Market Challenges
1.3.4 Preimplantation Genetic Diagnosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Preimplantation Genetic Diagnosis Players Revenue Ranking (2023)
2.2 Global Preimplantation Genetic Diagnosis Revenue by Company (2019-2024)
2.3 Key Companies Preimplantation Genetic Diagnosis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Preimplantation Genetic Diagnosis Product Offered
2.5 Key Companies Time to Begin Mass Production of Preimplantation Genetic Diagnosis
2.6 Preimplantation Genetic Diagnosis Market Competitive Analysis
2.6.1 Preimplantation Genetic Diagnosis Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Preimplantation Genetic Diagnosis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Genetic Diagnosis
3.1.2 Genetic Screening
3.2 Global Preimplantation Genetic Diagnosis Sales Value by Type
3.2.1 Global Preimplantation Genetic Diagnosis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Preimplantation Genetic Diagnosis Sales Value, by Type (2019-2030)
3.2.3 Global Preimplantation Genetic Diagnosis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Fertility Clinics
4.1.2 Research
4.2 Global Preimplantation Genetic Diagnosis Sales Value by Application
4.2.1 Global Preimplantation Genetic Diagnosis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Preimplantation Genetic Diagnosis Sales Value, by Application (2019-2030)
4.2.3 Global Preimplantation Genetic Diagnosis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Preimplantation Genetic Diagnosis Sales Value by Region
5.1.1 Global Preimplantation Genetic Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Preimplantation Genetic Diagnosis Sales Value by Region (2019-2024)
5.1.3 Global Preimplantation Genetic Diagnosis Sales Value by Region (2025-2030)
5.1.4 Global Preimplantation Genetic Diagnosis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Preimplantation Genetic Diagnosis Sales Value, 2019-2030
5.2.2 North America Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Preimplantation Genetic Diagnosis Sales Value, 2019-2030
5.3.2 Europe Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Preimplantation Genetic Diagnosis Sales Value, 2019-2030
5.4.2 Asia Pacific Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Preimplantation Genetic Diagnosis Sales Value, 2019-2030
5.5.2 South America Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Preimplantation Genetic Diagnosis Sales Value, 2019-2030
5.6.2 Middle East & Africa Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Preimplantation Genetic Diagnosis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Preimplantation Genetic Diagnosis Sales Value
6.3 United States
6.3.1 United States Preimplantation Genetic Diagnosis Sales Value, 2019-2030
6.3.2 United States Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Preimplantation Genetic Diagnosis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Preimplantation Genetic Diagnosis Sales Value, 2019-2030
6.4.2 Europe Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Preimplantation Genetic Diagnosis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Preimplantation Genetic Diagnosis Sales Value, 2019-2030
6.5.2 China Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Preimplantation Genetic Diagnosis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Preimplantation Genetic Diagnosis Sales Value, 2019-2030
6.6.2 Japan Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Preimplantation Genetic Diagnosis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Preimplantation Genetic Diagnosis Sales Value, 2019-2030
6.7.2 South Korea Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Preimplantation Genetic Diagnosis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Preimplantation Genetic Diagnosis Sales Value, 2019-2030
6.8.2 Southeast Asia Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Preimplantation Genetic Diagnosis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Preimplantation Genetic Diagnosis Sales Value, 2019-2030
6.9.2 India Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Preimplantation Genetic Diagnosis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumina, Inc.
7.1.1 Illumina, Inc. Profile
7.1.2 Illumina, Inc. Main Business
7.1.3 Illumina, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
7.1.4 Illumina, Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.1.5 Illumina, Inc. Recent Developments
7.2 Thermo Fisher Scientific Inc.
7.2.1 Thermo Fisher Scientific Inc. Profile
7.2.2 Thermo Fisher Scientific Inc. Main Business
7.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Inc. Recent Developments
7.3 Agilent Technologies, Inc.
7.3.1 Agilent Technologies, Inc. Profile
7.3.2 Agilent Technologies, Inc. Main Business
7.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
7.3.4 Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.3.5 Perkinelmer, Inc. Recent Developments
7.4 Perkinelmer, Inc.
7.4.1 Perkinelmer, Inc. Profile
7.4.2 Perkinelmer, Inc. Main Business
7.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
7.4.4 Perkinelmer, Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.4.5 Perkinelmer, Inc. Recent Developments
7.5 Coopersurgical
7.5.1 Coopersurgical Profile
7.5.2 Coopersurgical Main Business
7.5.3 Coopersurgical Preimplantation Genetic Diagnosis Products, Services and Solutions
7.5.4 Coopersurgical Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.5.5 Coopersurgical Recent Developments
7.6 ABBott Laboratories
7.6.1 ABBott Laboratories Profile
7.6.2 ABBott Laboratories Main Business
7.6.3 ABBott Laboratories Preimplantation Genetic Diagnosis Products, Services and Solutions
7.6.4 ABBott Laboratories Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.6.5 ABBott Laboratories Recent Developments
7.7 Natera, Inc.
7.7.1 Natera, Inc. Profile
7.7.2 Natera, Inc. Main Business
7.7.3 Natera, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
7.7.4 Natera, Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.7.5 Natera, Inc. Recent Developments
7.8 Rubicon Genomics
7.8.1 Rubicon Genomics Profile
7.8.2 Rubicon Genomics Main Business
7.8.3 Rubicon Genomics Preimplantation Genetic Diagnosis Products, Services and Solutions
7.8.4 Rubicon Genomics Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.8.5 Rubicon Genomics Recent Developments
7.9 Oxford Gene Technology
7.9.1 Oxford Gene Technology Profile
7.9.2 Oxford Gene Technology Main Business
7.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis Products, Services and Solutions
7.9.4 Oxford Gene Technology Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.9.5 Oxford Gene Technology Recent Developments
7.10 Yikon Genomics
7.10.1 Yikon Genomics Profile
7.10.2 Yikon Genomics Main Business
7.10.3 Yikon Genomics Preimplantation Genetic Diagnosis Products, Services and Solutions
7.10.4 Yikon Genomics Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.10.5 Yikon Genomics Recent Developments
7.11 Scigene
7.11.1 Scigene Profile
7.11.2 Scigene Main Business
7.11.3 Scigene Preimplantation Genetic Diagnosis Products, Services and Solutions
7.11.4 Scigene Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2019-2024)
7.11.5 Scigene Recent Developments
8 Industry Chain Analysis
8.1 Preimplantation Genetic Diagnosis Industrial Chain
8.2 Preimplantation Genetic Diagnosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Preimplantation Genetic Diagnosis Sales Model
8.5.2 Sales Channel
8.5.3 Preimplantation Genetic Diagnosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Preimplantation Genetic Diagnosis Market Trends
    Table 2. Preimplantation Genetic Diagnosis Market Drivers & Opportunity
    Table 3. Preimplantation Genetic Diagnosis Market Challenges
    Table 4. Preimplantation Genetic Diagnosis Market Restraints
    Table 5. Global Preimplantation Genetic Diagnosis Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Preimplantation Genetic Diagnosis Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Preimplantation Genetic Diagnosis Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Preimplantation Genetic Diagnosis Product Type
    Table 9. Key Companies Time to Begin Mass Production of Preimplantation Genetic Diagnosis
    Table 10. Global Preimplantation Genetic Diagnosis Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Preimplantation Genetic Diagnosis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Preimplantation Genetic Diagnosis Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Preimplantation Genetic Diagnosis Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Preimplantation Genetic Diagnosis Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Preimplantation Genetic Diagnosis Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Preimplantation Genetic Diagnosis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Preimplantation Genetic Diagnosis Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Preimplantation Genetic Diagnosis Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Preimplantation Genetic Diagnosis Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Preimplantation Genetic Diagnosis Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Preimplantation Genetic Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Preimplantation Genetic Diagnosis Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Preimplantation Genetic Diagnosis Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Preimplantation Genetic Diagnosis Sales Value by Region (2019-2024) & (%)
    Table 27. Global Preimplantation Genetic Diagnosis Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Preimplantation Genetic Diagnosis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Preimplantation Genetic Diagnosis Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Preimplantation Genetic Diagnosis Sales Value, (2025-2030) & (US$ Million)
    Table 31. Illumina, Inc. Basic Information List
    Table 32. Illumina, Inc. Description and Business Overview
    Table 33. Illumina, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Illumina, Inc. (2019-2024)
    Table 35. Illumina, Inc. Recent Developments
    Table 36. Thermo Fisher Scientific Inc. Basic Information List
    Table 37. Thermo Fisher Scientific Inc. Description and Business Overview
    Table 38. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Thermo Fisher Scientific Inc. (2019-2024)
    Table 40. Thermo Fisher Scientific Inc. Recent Developments
    Table 41. Agilent Technologies, Inc. Basic Information List
    Table 42. Agilent Technologies, Inc. Description and Business Overview
    Table 43. Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Agilent Technologies, Inc. (2019-2024)
    Table 45. Agilent Technologies, Inc. Recent Developments
    Table 46. Perkinelmer, Inc. Basic Information List
    Table 47. Perkinelmer, Inc. Description and Business Overview
    Table 48. Perkinelmer, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Perkinelmer, Inc. (2019-2024)
    Table 50. Perkinelmer, Inc. Recent Developments
    Table 51. Coopersurgical Basic Information List
    Table 52. Coopersurgical Description and Business Overview
    Table 53. Coopersurgical Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Coopersurgical (2019-2024)
    Table 55. Coopersurgical Recent Developments
    Table 56. ABBott Laboratories Basic Information List
    Table 57. ABBott Laboratories Description and Business Overview
    Table 58. ABBott Laboratories Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of ABBott Laboratories (2019-2024)
    Table 60. ABBott Laboratories Recent Developments
    Table 61. Natera, Inc. Basic Information List
    Table 62. Natera, Inc. Description and Business Overview
    Table 63. Natera, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Natera, Inc. (2019-2024)
    Table 65. Natera, Inc. Recent Developments
    Table 66. Rubicon Genomics Basic Information List
    Table 67. Rubicon Genomics Description and Business Overview
    Table 68. Rubicon Genomics Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Rubicon Genomics (2019-2024)
    Table 70. Rubicon Genomics Recent Developments
    Table 71. Oxford Gene Technology Basic Information List
    Table 72. Oxford Gene Technology Description and Business Overview
    Table 73. Oxford Gene Technology Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Oxford Gene Technology (2019-2024)
    Table 75. Oxford Gene Technology Recent Developments
    Table 76. Yikon Genomics Basic Information List
    Table 77. Yikon Genomics Description and Business Overview
    Table 78. Yikon Genomics Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Yikon Genomics (2019-2024)
    Table 80. Yikon Genomics Recent Developments
    Table 81. Scigene Basic Information List
    Table 82. Scigene Description and Business Overview
    Table 83. Scigene Preimplantation Genetic Diagnosis Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Preimplantation Genetic Diagnosis Business of Scigene (2019-2024)
    Table 85. Scigene Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Preimplantation Genetic Diagnosis Downstream Customers
    Table 89. Preimplantation Genetic Diagnosis Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Preimplantation Genetic Diagnosis Product Picture
    Figure 2. Global Preimplantation Genetic Diagnosis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Preimplantation Genetic Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 4. Preimplantation Genetic Diagnosis Report Years Considered
    Figure 5. Global Preimplantation Genetic Diagnosis Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Preimplantation Genetic Diagnosis Revenue in 2023
    Figure 7. Preimplantation Genetic Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Genetic Diagnosis Picture
    Figure 9. Genetic Screening Picture
    Figure 10. Global Preimplantation Genetic Diagnosis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Preimplantation Genetic Diagnosis Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Fertility Clinics
    Figure 13. Product Picture of Research
    Figure 14. Global Preimplantation Genetic Diagnosis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Preimplantation Genetic Diagnosis Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Preimplantation Genetic Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Preimplantation Genetic Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Preimplantation Genetic Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Preimplantation Genetic Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Preimplantation Genetic Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Preimplantation Genetic Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Preimplantation Genetic Diagnosis Sales Value (%), (2019-2030)
    Figure 27. United States Preimplantation Genetic Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Preimplantation Genetic Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Preimplantation Genetic Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Preimplantation Genetic Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Preimplantation Genetic Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Preimplantation Genetic Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Preimplantation Genetic Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Preimplantation Genetic Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Preimplantation Genetic Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Preimplantation Genetic Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Preimplantation Genetic Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Preimplantation Genetic Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Preimplantation Genetic Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Preimplantation Genetic Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Preimplantation Genetic Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 48. Preimplantation Genetic Diagnosis Industrial Chain
    Figure 49. Preimplantation Genetic Diagnosis Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Intra-Uterine Contraceptive Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-2K7710
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Umbilical Cord Clamp - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-22J7627
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Preimplantation Genetic Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35H2599
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Umbilical Catheters - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-32Z13567
Mon Oct 07 00:00:00 UTC 2024

Add to Cart